Why is Shree Ganesh Bio falling/rising?

As of 18-Sep, Shree Ganesh Biotech India Ltd is currently priced at 0.79, showing no change (0.00%). The stock has underperformed in the short term, with a 1-week return of 0.00% and a 1-month return also at 0.00%. However, it has outperformed its sector by 0.82% today. The stock is trading above its 20-day moving average but below its 5-day, 50-day, 100-day, and 200-day moving averages. Notably, there has been a rise in investor participation, with delivery volume increasing by 13.38% against the 5-day average. Despite these positive indicators, the company faces significant challenges, including operating losses and a weak ability to service its debt, reflected in a poor EBIT to Interest ratio of 0.97. Additionally, the stock has generated a return of -28.83% over the past year, with profits falling by -48%, indicating low profitability.
In the broader market context, the Sensex has shown a positive trend, with a 1-week return of +1.80% and a 1-month return of +2.14%. This suggests that while the overall market is performing well, Shree Ganesh Biotech India Ltd is lagging significantly, particularly with a year-to-date return of -24.04% compared to the Sensex's +6.24%. The stark contrast between the stock's performance and the benchmark highlights the company's ongoing struggles, which are compounded by its weak long-term fundamental strength and negative EBITDA, making it a risky investment in the current market environment.